KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Inventory Average (2016 - 2025)

Historic Inventory Average for Bristol Myers Squibb (BMY) over the last 16 years, with Q3 2025 value amounting to $2.7 billion.

  • Bristol Myers Squibb's Inventory Average fell 1426.12% to $2.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 billion, marking a year-over-year decrease of 1426.12%. This contributed to the annual value of $2.6 billion for FY2024, which is 435.91% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported Inventory Average of $2.7 billion as of Q3 2025, which was down 1426.12% from $2.7 billion recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Inventory Average ranged from a high of $3.2 billion in Q3 2024 and a low of $2.0 billion during Q1 2021
  • For the 5-year period, Bristol Myers Squibb's Inventory Average averaged around $2.5 billion, with its median value being $2.5 billion (2023).
  • As far as peak fluctuations go, Bristol Myers Squibb's Inventory Average plummeted by 4351.24% in 2021, and later skyrocketed by 3352.08% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Inventory Average stood at $2.1 billion in 2021, then grew by 3.64% to $2.2 billion in 2022, then rose by 15.52% to $2.5 billion in 2023, then rose by 15.52% to $2.9 billion in 2024, then dropped by 6.69% to $2.7 billion in 2025.
  • Its last three reported values are $2.7 billion in Q3 2025, $2.7 billion for Q2 2025, and $2.6 billion during Q1 2025.